Home > Category > Signaling Pathways > Cytoskeletal Signaling > Integrin > Tadocizumab

Tadocizumab

ChemLeader 95+%
Catalog No:CLA1084 CAS No.:339086-80-5 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $850.00 Visible after login
- +
5 mg 3-5days $3300.00 Visible after login
- +
10 mg 3-5days $5500.00 Visible after login
- +
50 mg 3-5days $22000.00 Visible after login
- +
100 mg 3-5days $42000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Tadocizumab
CAS339086-80-5
Storage conditionSealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles
Product details

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays